Cargando…
Removing N-Terminal Sequences in Pre-S1 Domain Enhanced Antibody and B-Cell Responses by an HBV Large Surface Antigen DNA Vaccine
Although the use of recombinant hepatitis B virus surface (HBsAg) protein vaccine has successfully reduced global hepatitis B infection, there are still a number of vaccine recipients who do not develop detectable antibody responses. Various novel vaccination approaches, including DNA vaccines, have...
Autores principales: | Ge, Guohong, Wang, Shixia, Han, Yaping, Zhang, Chunhua, Lu, Shan, Huang, Zuhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402421/ https://www.ncbi.nlm.nih.gov/pubmed/22844502 http://dx.doi.org/10.1371/journal.pone.0041573 |
Ejemplares similares
-
Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants
por: Zhang, Mingshun, et al.
Publicado: (2013) -
Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses
por: Wang, Shixia, et al.
Publicado: (2011) -
Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection
por: Rodgers, Mary A., et al.
Publicado: (2023) -
Clostridium difficile infections in China()
por: Jin, Ke, et al.
Publicado: (2010) -
Occult HBV among Anti-HBc Alone: Mutation Analysis of an HBV Surface Gene and Pre-S Gene
por: Kim, Myeong Hee, et al.
Publicado: (2017)